GrowBLOX Sciences News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

22.05.18	GB Sciences Will Now Serve A Greatly Expanded Patient Base In Louisiana With The Addition Of Autism, Glaucoma, Parkinson's, PTSD, Intractable Pain And Severe Muscle Spasms To The List Of Ailments... (PR Newswire)
22.05.18	GB Sciences Will Now Serve A Greatly Expanded Patient Base In Louisiana With The Addition Of Autism, Glaucoma, Parkinson's, PTSD, Intractable Pain And Severe Muscle Spasms To The List Of Ailments... (PR Newswire)
09.05.18	GB Sciences' Acquisition Of NevadaPURE Is Terminated (PR Newswire)
09.05.18	GB Sciences' Acquisition Of NevadaPURE Is Terminated (PR Newswire)
17.04.18	Exploratory IND Is Planned Using GB Sciences' Proprietary Mixtures of Botanical Compounds to Provide the Highest Efficacy for Patients (PR Newswire)
17.04.18	Exploratory IND Is Planned Using GB Sciences' Proprietary Mixtures of Botanical Compounds to Provide the Highest Efficacy for Patients (PR Newswire)
12.04.18	GB Sciences Announces the Appointment of John B. Davis as Executive VP and General Counsel (PR Newswire)
12.04.18	GB Sciences Announces the Appointment of John B. Davis as Executive VP and General Counsel (PR Newswire)
10.04.18	GB Sciences Pursues FDA-Registered, First-in-Human Trial of Cannabis-based Therapy for Parkinson's Disease (PR Newswire)
10.04.18	GB Sciences Pursues FDA-Registered, First-in-Human Trial of Cannabis-based Therapy for Parkinson's Disease (PR Newswire)
04.04.18	GB Sciences Completes Nanotechnology Transfer of Exclusively-Licensed, Cannabinoid-Based, Time-Released Neuropathic Pain Formula (PR Newswire)
04.04.18	GB Sciences Completes Nanotechnology Transfer of Exclusively-Licensed, Cannabinoid-Based, Time-Released Neuropathic Pain Formula (PR Newswire)
28.03.18	GB Sciences Signs Letter of Intent to Acquire NevadaPURE's Las Vegas Operations: Gaining $16 Million in Annualized Revenues (PR Newswire)
28.03.18	GB Sciences Signs Letter of Intent to Acquire NevadaPURE's Las Vegas Operations: Gaining $16 Million in Annualized Revenues (PR Newswire)
15.03.18	GB Sciences Sponsors "Innovation in Medical Cannabis Therapies" Symposium (PR Newswire)
15.03.18	GB Sciences Sponsors "Innovation in Medical Cannabis Therapies" Symposium (PR Newswire)
27.02.18	GB Sciences, Inc. Enters A New Market by Signing a Contract Farming Agreement for the Development of Boutique Hemp Genetics with the Colorado Hemp Project (PR Newswire)
27.02.18	GB Sciences, Inc. Enters A New Market by Signing a Contract Farming Agreement for the Development of Boutique Hemp Genetics with the Colorado Hemp Project (PR Newswire)
21.02.18	GB Sciences Receives Issuance of Its Cannabis Oil Production License (PR Newswire)
21.02.18	GB Sciences Receives Issuance of Its Cannabis Oil Production License (PR Newswire)
14.02.18	GB Sciences Partners with Wellcana Group, LLC. in the Development of Medical Cannabis in Louisiana (PR Newswire)
14.02.18	GB Sciences Partners with Wellcana Group, LLC. in the Development of Medical Cannabis in Louisiana (PR Newswire)
05.02.18	GB Sciences Files a Nonprovisional Patent Application for Cannabis-Based Anti-Inflammatory Therapies Including Arthritis, Asthma, Eczema and More (PR Newswire)
05.02.18	GB Sciences Files a Nonprovisional Patent Application for Cannabis-Based Anti-Inflammatory Therapies Including Arthritis, Asthma, Eczema and More (PR Newswire)
25.01.18	GB Sciences Welcomes Dr. Zoltan Mari, A Nationally Recognized Expert on the Study and Treatment of Parkinson's Disease to Their Scientific Advisory Board (PR Newswire)
25.01.18	GB Sciences Welcomes Dr. Zoltan Mari, A Nationally Recognized Expert on the Study and Treatment of Parkinson's Disease to Their Scientific Advisory Board (PR Newswire)
08.01.18	GB Sciences Is Maximizing the Production of Critical Medical Components from Specific Cannabis Strains (PR Newswire)
08.01.18	GB Sciences Is Maximizing the Production of Critical Medical Components from Specific Cannabis Strains (PR Newswire)
26.12.17	GB Sciences' Chief Science Officer, Dr. Andrea Small-Howard, Has Been Invited to Join the Medical Cannabis in Neuroscience Panel at The Neuroscience Innovation Forum for BD&L and Investment in... (PR Newswire)
26.12.17	GB Sciences' Chief Science Officer, Dr. Andrea Small-Howard, Has Been Invited to Join the Medical Cannabis in Neuroscience Panel at The Neuroscience Innovation Forum for BD&L and Investment in... (PR Newswire)
13.12.17	GB Sciences: Develops Extremely High THC Content Cannabis Strain With Maximized Terpene Levels To Increase Medical Benefits (PR Newswire)
13.12.17	GB Sciences: Develops Extremely High THC Content Cannabis Strain With Maximized Terpene Levels To Increase Medical Benefits (PR Newswire)
05.12.17	GB Sciences Announces Tissue Propagation Breakthrough In Commercial Cannabis Cultivation (PR Newswire)
05.12.17	GB Sciences Announces Tissue Propagation Breakthrough In Commercial Cannabis Cultivation (PR Newswire)
15.11.17	GB Sciences Exceeds Its Gross Revenue Projections for October, Doubles the Industry Average Yield Per Active Flower Light (PR Newswire)
15.11.17	GB Sciences Exceeds Its Gross Revenue Projections for October, Doubles the Industry Average Yield Per Active Flower Light (PR Newswire)
13.11.17	GB Sciences is Happy (PR Newswire)
01.11.17	GB Sciences Inducts Scientific Advisory Board: Dr. Andrea Small-Howard of GB Sciences, Dr. Helen Turner of Chaminade University, Dr. Norbert Kaminsky of Michigan State University, and Dr. (PR Newswire)
30.10.17	GB Sciences, Inc. Partners With Cura Cannabis Solutions And Enters The Lucrative Cannabis Oil Market In Nevada (PR Newswire)
26.10.17	GB Sciences Receives The Prestigious 'Spirit Of The Law' Award (PR Newswire)
23.10.17	GB Sciences Increased Sales 400% Since First Harvest (PR Newswire)
17.10.17	GB Sciences Obtains Exclusive Worldwide License on a Time-Released Cannabinoid Formulation for Neuropathic Pain (PR Newswire)
10.10.17	Nanotechnology Research Collaboration with Universidad de Sevilla to Create Time-Released Formulation for GB Sciences' THC-Free Chronic Pain Therapy (PR Newswire)
18.09.17	Groundbreaking Collaboration Between A Major University And A Medical Cannabis Company (PR Newswire)
18.09.17	Innovative Partnership Forged Between LSU AgCenter And GB Sciences To Advance The Understanding Of The Cannabis Plant (PR Newswire)
14.09.17	Cannabis Legalization Gains Popularity (PR Newswire)
02.08.17	GB Sciences Joins With Los Coyotes Band Of Cahuilla And Cupeno Indians As It Enters The Gigantic California Cannabis Market (PR Newswire)
17.07.17	GB Sciences Initiates Cannabis-based Therapy Clinical Trials Consulting Services Agreement with Worldwide Clinical Trials, Inc. (PR Newswire)
10.07.17	GB Sciences Inc. Adds Provisional Nevada Recreational Cannabis License for Branded Recreational Products (PR Newswire)
05.07.17	GB Sciences Sells First Cannabis Harvest and Officially Enters Revenue Mode (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu GrowBLOX Sciences Inc

Aktien Top/Flop

Meistgelesene Nachrichten